EUVIMEDEUVIMED entdecken
Crossref

Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series

Saramma Abraham

APCRI Journal · 2023

DOI: 10.24321/0973.5038.202310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APCRI Journal, 2023. Verfasst von Saramma Abraham.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Rabies is a vaccine preventable zoonotic disease, however, if not prevented in time, it may become 100% fatal. Combining vaccine- immunoglobulin therapy with proper wound care is advised for effective rabies prevention. Equine rabies immunoglobulin is cheaper than human rabies immunoglobulin, but there is an increased chance of hypersensitivity reaction following its administration.

Method

A case series study has been presented in this article consisting of three different presentations of hypersensitivity reactions after the administration of equine rabies immunoglobulin.

Results

Two cases developed an immediate allergic reaction after desensitization. The third case showed a delayed local reaction and did not develop any allergy during the skin test before administering the full dose.

Conclusion

In a poor resource setting like India, skin sensitivity testing may be continued to identify high risk patients, and provide desentization, but still allergic reactions may be anticipated for them.

Zitieren

APA

Abraham, S. (2023). Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series. APCRI Journal. https://doi.org/10.24321/0973.5038.202310

Vancouver

Abraham S. Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series. APCRI Journal. 2023. doi:10.24321/0973.5038.202310

BibTeX
@article{Abraham2023,
  author = {Abraham, Saramma},
  title = {Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series},
  journal = {APCRI Journal},
  year = {2023},
  doi = {10.24321/0973.5038.202310}
}
Kostenlos starten →